A 12‐Week, Open Label, Multi‐Center Study to Evaluate the Clinical Efficacy and Safety of Silodosin on Voiding Dysfunction in Patients with Neurogenic Bladder

Publisher： John Wiley & Sons Inc

E-ISSN： 1757-5672|7|1|27-31

ISSN： 1757-5664

Source： LUTS, Vol.7, Iss.1, 2015-01, pp. : 27-31

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An Open-Label Extension Study to Evaluate Safety and Efficacy of Pazopanib in Patients with Advanced Renal Cell Carcinoma

By  

Oncology, Vol. 87, Iss. 6, 2014-09 ,pp. : 342-350

Karger

Access to resources Recommend Favorite

Safety and efficacy of mirabegron as ‘add‐on’ therapy in patients with overactive bladder treated with solifenacin: a post‐marketing, open‐label study in Japan (MILAI study)

By  

BJU INTERNATIONAL, Vol. 116, Iss. 4, 2015-10 ,pp. : 612-622

John Wiley & Sons Inc

Access to resources Recommend Favorite

Interventions do not enhance medication persistence and compliance in patients with overactive bladder: a 24 weeks, randomised, open‐label, multi‐center trial

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 11, 2015-11 ,pp. : 1309-1315

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of doripenem versus piperacillin/tazobactam in nosocomial pneumonia: a randomized, open-label, multicenter study*

By Réa-Neto Álvaro   Niederman Michael   Margareth Lobo Suzana   Schroeder Eric   Lee Michael   Kaniga Koné   Ketter Nzeera   Prokocimer Philippe   Friedland Ian  

Current Medical Research and Opinion, Vol. 24, Iss. 7, 2008-07 ,pp. : 2113-2126

Informa Healthcare

Access to resources Recommend Favorite

P057: Efficacy and safety of Peginterferon alfa‐2b (40 kD, Y Shape) (Pegberon) in HBeAg‐ positive CHB patients — a phase III, randomized, multicenter, positive‐controlled, open‐label clinical study

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 48-48

John Wiley & Sons Inc

Access to resources Recommend Favorite